Cindy Cavelier

Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2Rγc-deficient mice

Jean‐Emmanuel Sarry, Kathleen M. Murphy, Robin Perry et al. · Journal of Clinical Investigation · 2010 · 380 citations

Mixed-phenotype Acute Leukemia, Immunology, Stem Cell Biology +16

Constitutive Activation of the DNA Damage Signaling Pathway in Acute Myeloid Leukemia with Complex Karyotype: Potential Importance for Checkpoint Targeting Therapy

Cindy Cavelier, Christine Didier, Naïs Prade et al. · Cancer Research · 2009 · 80 citations · Full text

Hematological Malignancy, Chromatin, Genome Instability +13

G2/M checkpoint stringency is a key parameter in the sensitivity of AML cells to genotoxic stress

Christine Didier, Cindy Cavelier, Muriel Quaranta et al. · Oncogene · 2008 · 37 citations

Reductive Stress, Genome Instability, Cell Regulation +10

Do AML patients with DNMT3A exon 23 mutations benefit from idarubicin as compared to daunorubicin? A single center experience

Olivier LaRochelle, Sarah Bertoli, François Vergez et al. · Oncotarget · 2011 · 30 citations · Full text

Toulouse University Hospital, Mixed-phenotype Acute Leukemia, Genetics +17

Evaluation of Polo-like Kinase 1 inhibition on the G2/M checkpoint in Acute Myelocytic Leukaemia

Christine Didier, Cindy Cavelier, Muriel Quaranta et al. · European Journal of Pharmacology · 2008 · 26 citations

Hematological Malignancy, Acute Myelocytic Leukaemia, Medicine +11